NICE - ナイス・システムズ (NICE Ltd) ナイス・システムズ

 NICEのチャート


 NICEの企業情報

symbol NICE
会社名 NICE Ltd (ナイス・システムズ)
分野(sector) Technology   ハイテク
産業(industry) Computer Manufacturing  
業種 ソフトウェア   IT・通信(IT_Communications)
概要 事業概要 ナイス(NICE LTD.)(旧名:NICE-Systems Ltd.)は、顧客経験、ビジネスパフォーマンス、コンプライアンス及び金融犯罪を管理するのに役立つグローバルな企業ソフトウェアの提供者。同社は、カスタマー・インタラクション・ソリューションズと金融犯罪・コンプライアンスソリューションの2つの事業セグメントにより構成される。同社は、複数のチャネルとソースを通し、顧客とのコミュニケーション及びトランザクションを取得する。   ナイス・システムズは、イスラエルのマルチメディア・ソリュ―ション会社。電話、ウェブ、ラジオ、ビデオ通信などのマルチメディア・コンテンツおよび対話、取引などを管理・分析するソリュ―ションを手掛ける。ソリュ―ションに は、クロスチャンネル分析やマルチセンサ―解析のほか、関連専門サ―ビスがある。   NICE Ltd. engages in the provision of enterprise software solutions and services. It operates through the following segments: Customer Interactions Solutions, Security Solutions, and Financial Crime and Compliance Solutions. The Customer Interactions Solutions segment provides suites such as compliance and risk, workforce optimization, operational efficiency, customer experience, and sales and retention. The Security Solutions segment offers suites including incident debriefing and investigation; public safety emergency response optimization; video surveillance and analytics; situation management; and intelligence and law enforcement. The Financial Crime and Compliance Solutions segment includes for enterprise risk management, anti-money laundering, fraud prevention, and brokerage compliance services. The company was founded on September 28, 1986 and is headquartered in Raanana, Israel.
本社所在地 13 Zarchin Street P.O. Box 690 Ra'anana 4310602 ISR
代表者氏名 David Kostman デビッド・コストマン
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +972 9-775-3777
設立年月日 31656
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 5208人
url www.nice.com
nasdaq_url https://www.nasdaq.com/symbol/nice
adr_tso 42793186
EBITDA EBITDA(百万ドル) 329.83200
終値(lastsale) 108.18
時価総額(marketcap) 4629366861.48
時価総額 時価総額(百万ドル) 6535.288
売上高 売上高(百万ドル) 1392.474
企業価値(EV) 企業価値(EV)(百万ドル) 6476.415
当期純利益 当期純利益(百万ドル) 132.32200
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Nice Ltd (ADR) revenues increased 10% to $677.5M. Net income increased 53% to $57.8M. Revenues reflect Cloud increase of 30% to $212.4M Services increase of 12% to $354.3M. Net income benefited from Finance and other income (expense) net decrease of 44% to $6.9M (expense) Stock-based Compensation in R&D decrease of 7% to $4.1M (expense).

 NICEのテクニカル分析


 NICEのニュース

   Can you really beat pain without drugs?  2020/08/10 21:35:11 Daily Mail Online
The National Institute for Health and Care Excellence (NICE) last week warned that pills including paracetamol, should no longer be routinely prescribed to patients with chronic pain.
   Common painkillers should not be used for chronic pain, study suggests  2020/08/05 07:43:59 Inquirer Technology
According to a new study, aspirin, ibuprofen and paracetamol, common painkillers we are used to taking for mild fever or aches and pains, may cause more harm than good in the treatment of chronic pain. In a draft guideline published on Monday, Aug. 3, the United Kingdom's National Institute for Health and Care Excellence (Nice) announced that there is "little or no evidence" of the efficacy of commonly used medicines against primary chronic pain, which is defined as pain that lasts or reappears for longer than three months and is caused by physical incapacity or emotional distress. According to the announcement, analgesics don't diminish pain, improve quality of life or minimiz… Keep on reading: Common painkillers should not be used for chronic pain, study suggests
   Painkillers including paracetamol 'can do more harm than good'  2020/08/04 07:14:00 Evening Standard
Painkillers such as paracetamol, ibuprofen, aspirin and opioids can do “more harm than good” and should not be prescribed to treat chronic pain, health officials have said. The National Institute for Health and Care Excellence (Nice) said that there was “little or no evidence” the commonly used drugs for chronic primary pain made any difference to people’s quality of life,
   Painkillers such as aspirin 'do more harm than good' for chronic pain  2020/08/03 22:12:44 The Guardian
Nice say paracetamol, ibuprofen and opioids should not be prescribed for chronic pain Painkillers such as paracetamol, ibuprofen, aspirin and opioids can do “more harm than good” and should not be prescribed to treat chronic pain, health officials have said. The National Institute for Health and Care Excellence (Nice) said there was “little or no evidence” the commonly used drugs for chronic primary pain made any difference to people’s quality of life, pain or psychological distress. Continue reading…
   Painkillers should not be prescribed for chronic pain because they may do 'more harm than good'  2020/08/03 14:13:48 Daily Mail Online
There is 'little or no evidence' the commonly used drugs work, according to England's health regulators, the National Institute for Health and Care Excellence (Nice).
   Taking vitamin D does not lower risk of Covid-19, health experts say  2020/06/29 21:13:39 Evening Standard
Taking vitamin D supplements does not help prevent or treat Covid-19, health officials have said. Officials from the National Institute for Health and Care Excellence (Nice) launched a rapid review of evidence in response to claims that the vitamin could reduce the risk of acute respiratory tract infections and Covid-19.
   Taking vitamin D supplements WON'T protect you from Covid-19, UK health chiefs rule  2020/06/29 16:23:47 Daily Mail Online
NHS watchdog the National Institute for Health and Care Excellence (NICE) reviewed studies into vitamin D and Covid-19 and found no evidence it protects people.
   Nice (NICE) Hits Fresh High: Is There Still Room to Run?  2020/05/25 13:15:06 Zacks Investment Research
Nice (NICE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
   Global Physical Security Information Management (PSIM) Market Analysis 2020-2024, Featuring CNL Software Ltd., Hexagon AB, NICE Ltd. and Robert Bosch GmbH - ResearchAndMarkets.com  2020/05/20 17:26:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Physical Security Information Management (PSIM) Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The physical security information management (PSIM) market is poised to grow by $ 2.59 bn during 2020-2024 progressing at a CAGR of 21% during the forecast period. This report on the physical security information management (PSIM) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as
   NICE Beats on Q1 Earnings & Revenues, Scraps 2020 Guidance  2020/05/15 09:51:00 Zacks Investment Research
NICE's (NICE) first-quarter 2020 results benefit from robust cloud revenues and an expanding customer base despite the coronavirus headwind.
   Taking vitamin D does not lower risk of Covid-19, health experts say  2020/06/29 21:13:39 Evening Standard
Taking vitamin D supplements does not help prevent or treat Covid-19, health officials have said. Officials from the National Institute for Health and Care Excellence (Nice) launched a rapid review of evidence in response to claims that the vitamin could reduce the risk of acute respiratory tract infections and Covid-19.
   Taking vitamin D supplements WON'T protect you from Covid-19, UK health chiefs rule  2020/06/29 16:23:47 Daily Mail Online
NHS watchdog the National Institute for Health and Care Excellence (NICE) reviewed studies into vitamin D and Covid-19 and found no evidence it protects people.
   Nice (NICE) Hits Fresh High: Is There Still Room to Run?  2020/05/25 13:15:06 Zacks Investment Research
Nice (NICE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
   Global Physical Security Information Management (PSIM) Market Analysis 2020-2024, Featuring CNL Software Ltd., Hexagon AB, NICE Ltd. and Robert Bosch GmbH - ResearchAndMarkets.com  2020/05/20 17:26:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Physical Security Information Management (PSIM) Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The physical security information management (PSIM) market is poised to grow by $ 2.59 bn during 2020-2024 progressing at a CAGR of 21% during the forecast period. This report on the physical security information management (PSIM) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as
   NICE Beats on Q1 Earnings & Revenues, Scraps 2020 Guidance  2020/05/15 09:51:00 Zacks Investment Research
NICE's (NICE) first-quarter 2020 results benefit from robust cloud revenues and an expanding customer base despite the coronavirus headwind.

 関連キーワード  (IT 米国株 ナイス・システムズ NICE NICE Ltd)

 twitter  (公式ツイッターやCEOツイッターなど)